why choose us

First received: March 17, 2023

Clinical Trial: Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung Non-Small Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: Phase II Randomized Controlled Trial of Biologically Guided Stereotactic Body Radiation Therapy in Oligoprogressive Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Brief Summary: This phase II trial tests the safety of positron emission tomography (PET) guided stereotactic body radiation therapy (SBRT) and how well it works to treat non-small cell lung cancer (NSCLC), melanoma, and renal cell carcinoma (RCC) that has up to 5 sites of progression (oligoprogression) compared to standard SBRT.SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision.This method may kill tumor cells with fewer doses over a shorter period and cause less damage to…

Read more